Relationship between CK19 mRNA expression in peripheral blood cells and the clinical factors of breast cancer patients with axillary lymph node-negative
Ya-xin ZHAO,Jie-fan LIU,Wei-jian SUN,Jin-su CHEN,Jin-ying ZHENG,Min ZHENG,Jun-dong TANG
DOI: https://doi.org/10.16073/j.cnki.cjcpt.2010.24.007
2010-01-01
Abstract:OBJECTIVE: To observe the CK19 mRNA expression in peripheral blood cells of breast cancer patients with axillary lymph node-negative, and then discuss the relationship between the CK19 mRNA expression and the clinical factors. METHODS: Peripheral blood samples were collected from 113 beast cancer patients and 30 female healthy volunteers, and RT-PCR was used to detect the CK19 mRNA expression in the perpheral blood cells. The relationship were analysed between the CK19 mRNA expression in the perpheral blood cells and the age of patients, tumour sizes, patients menstrual status, histology grading, pathology category, TNM staging, estrogen receptor expression, progesterone receptor expression, HER-2 expression and Ki-67 proliferation expression. RESULTS: The positive rates of CK19 mRNA expression in the perpheral blood cells were 36.3% (41/113) and 3.3% (1/30) respectively in breast cancer patients and female healthy volunteers, there were significant difference between two groups (P=0.000). There were not associativity between the CK19 mRNA expression of the perpheral blood cells of breast cancer patients and the age of breast cancer patients, menstrual status, estrogen receptor expression, and progesterone receptor expression (P>0.05). But there were dependability between the CK19 mRNA expression of the perpheral blood cells of breast cancer patients and tumour sizes, histology grading, pathology category, TNM staging, HER-2 expression, and Ki-67 proliferation expression (P<0.05). CONCLUSIONS: The CK19 mRNA expression is a sensitive micrometastasiss indicator. These indexes, including tumour sizes, histology grading, pathology category, TNM staging, HER-2 expression, and Ki-67 proliferation expression, are effective predictors of micrometastasis in the peripheral blood of breast cancer patients with axillary lymph node-negative.